Trans-4-(4-Methoxyphenyl)Pyrrolidine-3-Carboxylic Acid-Hcl

Trans-4-(4-Methoxyphenyl)Pyrrolidine-3-Carboxylic Acid-Hcl


    • Product Name Trans-4-(4-Methoxyphenyl)Pyrrolidine-3-Carboxylic Acid-Hcl
    • Alias HYR-071
    • Einecs 872326-15-3
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    848790

    Chemical Name Trans-4-(4-Methoxyphenyl)Pyrrolidine-3-Carboxylic Acid-Hcl

    As an accredited Trans-4-(4-Methoxyphenyl)Pyrrolidine-3-Carboxylic Acid-Hcl factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Trans - 4 - (4 - Methoxyphenyl)Pyrrolidine - 3 - Carboxylic Acid - Hcl in sealed chemical - grade bags.
    Shipping Trans - 4 - (4 - Methoxyphenyl)Pyrrolidine - 3 - Carboxylic Acid - HCl will be shipped in a well - sealed, corrosion - resistant container. Packaging adheres to chemical shipping safety standards to prevent leakage during transit.
    Storage Trans - 4 - (4 - Methoxyphenyl)pyrrolidine - 3 - carboxylic acid - HCl should be stored in a cool, dry place, away from direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. Store it at a controlled temperature, typically around room temperature (15 - 25°C), to maintain its chemical stability.
    Application of Trans-4-(4-Methoxyphenyl)Pyrrolidine-3-Carboxylic Acid-Hcl
    In the pursuit of selective norepinephrine reuptake inhibitors with attenuated muscarinic antagonism, trans-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride is introduced as the chiral linchpin in a multi-kilogram manufacturing route that bypasses classical resolution. The hydrochloride salt is first neutralised with aqueous sodium hydroxide (2.0 M) in ethyl acetate at 15–20°C; the organic layer is azeotropically dried to <100 ppm water (Karl Fischer, USP <921>) before charging into the amidation. Coupling with 2-(2-ethoxyphenoxy)ethylamine (1.02 molar equiv.) proceeds via 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.20 equiv.) and 1-hydroxybenzotriazole hydrate (0.10 equiv.) in N,N-dimethylformamide at −2 to 3°C for 12 h. After aqueous workup with 5% sodium bicarbonate and brine, the N-Boc protected amide is crystallised from cyclohexane/methyl tert-butyl ether (3:1 v/v) to afford a white solid with 99.3% HPLC purity (Waters Symmetry C18, 150×4.6 mm, acetonitrile/0.1% phosphoric acid gradient, UV 215 nm) and 99.8% ee (Chiralpak AD-H, 250×4.6 mm, n-hexane/ethanol/diethylamine 88/12/0.1, retention time 7.2 min). The penultimate intermediate is telescoped into a two-step deprotection-reductive methylation: first, trifluoroacetic acid (8.0 equiv.) in dichloromethane at 20°C for 3 h cleaves the Boc group; after solvent exchange to methanol, formaldehyde (37 wt% in water, 3.5 equiv.) and sodium cyanoborohydride (2.0 equiv.) are added at pH 5.0–5.5 (adjusted with acetic acid), maintaining 10–15°C. The resulting tertiary amine API—a dual norepinephrine-dopamine reuptake inhibitor—is isolated as the fumarate salt, displaying a Ki of 8.7 nM at hNET and 42 nM at hDAT in competition binding assays. Batch records from 50-L glass-lined reactors indicate that the hydrogen chloride content of the starting material must be strictly controlled (18.5–19.2% titration) because deviations exceeding 0.5% shift the amidation pH window and drop the diastereomeric excess below 98.5%. The product is shipped under nitrogen in double polyamide-aluminium foil bags with a maximum storage recommendation of 24 months at 2–8°C, supported by long-term stability data per ICH Q1A(R2) showing 0.15% total degradants at 36 months.A structurally diverse set of trans-4-aryl pyrrolidine-3-carboxamide ligands was advanced to preclinical toxicology for the treatment of neuropathic pain, exploiting this pyrrolidine acid as the common advanced intermediate. Following liberation of the free amine with potassium carbonate (2.5 equiv.) in isopropyl acetate, the pyrrolidine ester—prepared by treating the acid with thionyl chloride (1.10 equiv.) in methanol at −8°C and subsequent heating to reflux for 5 h—is subjected to lithium aluminium hydride reduction (1.50 equiv. in tetrahydrofuran, 0°C to 20°C over 2 h) to furnish the primary alcohol. This alcohol is converted to the corresponding mesylate (> 99% conversion by TLC) and displaced with selected substituted phenols under Mitsunobu conditions (diisopropyl azodicarboxylate 1.30 equiv., triphenylphosphine 1.30 equiv.) in toluene at 25°C, providing ether-linked candidates that maintain the trans geometry unambiguously (3JHH = 7.8–8.2 Hz in 400 MHz 1H NMR). The free base of the final ether is treated with hydrochloric acid in dioxane (4.0 M, 1.05 equiv.) to deliver the hydrochloride salt directly amenable to salt-form screening. A μ-opioid receptor agonist emerging from this series showed an EC50 of 3.4 nM in [35S]GTPγS functional assays and exceeded 95% oral bioavailability in male Sprague-Dawley rats when administered at 5 mg/kg. Critical process controls in the larger-scale (20-kg) campaigns included the residual aluminium content of the reduced alcohol intermediate, which had to be brought below 10 ppm (ICP-MS, USP <233>) by acidic Celite filtration to avoid emulsion formation in the Mitsunobu workup. The enantiospecific synthesis demands that any batch of the pyrrolidine acid hydrochloride containing more than 0.15% of the cis isomer be rejected, an attribute verified by an orthogonal capillary electrophoresis method (BGE: 50 mM sodium phosphate, pH 2.5, with 2% sulfated-β-cyclodextrin).

    Why Does the Purity Profile of the In-Situ Generated Acid Chloride Impact Asymmetric Alkylation Yields?

    When the pyrrolidine carboxylic acid is repurposed as a chiral controller in glycine Schiff base alkylations, the mode of activation directly dictates the diastereomeric ratio. Prior to use, the hydrochloride salt is suspended in dichloromethane and treated with triethylamine (2.20 equiv.) at 0–5°C; the liberated free acid is then added dropwise to a pre-mixed solution of oxalyl chloride (1.08 equiv.) and catalytic dimethylformamide (0.5 mol%) in the same solvent. If the resulting acid chloride solution is not degassed under vacuum (50 mbar for 15 min at 10°C) to expel residual HCl, the subsequent coupling with 2-aminobenzophenone-derived imine proceeds with 6–8% lower selectivity. The optimized protocol loads this acid chloride at −78°C into a lithium enolate formed from tert-butyl glycinate Schiff base and lithium bis(trimethylsilyl)amide (1.10 equiv. in THF). After 45 min at −78°C and quenching with glacial acetic acid (2.00 equiv.), the resultant protected β-aryl pyrrolidine amino acid—a core of constrained peptidomimetics—is obtained in 91% isolated yield and 99.2% de. The diastereomeric excess is sensitive to the alkali metal counterion: lithium base yields a dr of 99:1, whereas sodium hexamethyldisilazide drops the dr to 87:13 under identical conditions. Scale-up in 30-L jacketed reactors equipped with a −85°C circulating bath revealed that the stirring rate during the acid chloride addition must be kept at 350–400 rpm (anchor impeller) to prevent hotspots that locally raise the temperature above −65°C and form the opposite diastereomer. The final deprotected tert-butyl ester hydrochloride is routinely certified against ISO 9001:2015 for customers employing it as a non-coded amino acid in solid-phase peptide synthesis (SPPS) on 2-chlorotrityl chloride resin (loading capacity 1.0–1.2 mmol/g).

    Precursor for [11C]Methoxy-Labeled Neuroinflammation Imaging Agents

    The free base of this pyrrolidine derivative, freed immediately before use with sodium bicarbonate, serves as a high-affinity precursor for O-[11C]methylation in the preparation of translocator protein (TSPO) radioligands. Within a lead-shielded hot cell, the precursor (0.5 mg, 2.2 µmol) is dissolved in anhydrous N,N-dimethylformamide (300 µL) containing cesium carbonate (2.5 mg, 7.7 µmol). Cyclotron-produced [11C]methyl iodide (typical activity 55–74 GBq at end of bombardment) is bubbled into the solution at 25°C for 2 min. The reaction vial is sealed and heated at 80°C for 5 min, after which the crude mixture is diluted with 1.5 mL of water and injected onto a semi-preparative HPLC system (YMC-Pack ODS-A, 250×10 mm, 5 µm; mobile phase acetonitrile/0.1% phosphoric acid 45:55 v/v, flow rate 4.0 mL/min). The radiolabeled product elutes at 9.2–9.6 min and is collected into a flask containing 50 mL of water and 0.5 mL of 7.5% sodium bicarbonate, then trapped on a C18 Plus solid-phase extraction cartridge, washed with sterile water (10 mL), and eluted with absolute ethanol (1.5 mL). The final formulation, diluted with 10 mL of 0.9% sodium chloride for injection, passes release tests per USP <823>: radiochemical purity ≥99.0% (HPLC, UV 254 nm co-injection with the non-radioactive reference), molar activity 180–260 GBq/µmol, residual DMF ≤880 ppm, and ethanol content 9.8–10.2% v/v. Visual inspection under 20,000 lux confirms the absence of particulates. The entire synthesis, from end of bombardment to final sterile filtration through a 0.22 µm membrane, is completed within 33–37 min, compliant with the 60-min valid shelf life determined by radiolysis kinetics. Batch failure most commonly arises when the precursor free base has been stored in solution for more than 20 min prior to labeling, during which oxidative discoloration generates by-products that co-elute with the radiopeak; hence, the precursor is supplied in single-use, argon-flushed amber vials containing 5.0 mg of hydrochloride salt, which must be reconstituted immediately before radiosynthesis.
    Table 1 — Labeling Performance as a Function of Precursor Purity
    Precursor Purity (HPLC, %)Radiochemical Yield (% EOB, decay-corrected)Molar Activity (GBq/µmol)Isolated Product Purity (%)
    99.832±2245±2099.7
    98.526±3190±3098.9
    97.218±4140±3597.2

    When the Pyrrolidine-3-Carboxylic Acid Framework Competes with L-Proline in Hepatitis C Protease Macrocycle Design

    Conformational restriction of P2 proline residues in NS3/4A protease inhibitors has motivated the deployment of this trans-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid as a rigidified replacement in hexapeptide macrocycles. The Fmoc-protected derivative (Fmoc-trans-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid) is prepared by treating the hydrochloride salt with Fmoc-OSu (1.15 equiv.) and N,N-diisopropylethylamine (3.00 equiv.) in water/acetonitrile (1:1 v/v) at 20–25°C for 16 h. After acidification and extraction, the Fmoc-amino acid crystallizes from diethyl ether/hexane (1:5) in 92% yield as a single diastereomer. On an automated peptide synthesizer (CEM Liberty Blue, 0.10 mmol scale), this building block is coupled to the growing peptide chain on 2-chlorotrityl chloride resin (substitution 0.78 mmol/g) using HATU (4.00 equiv.) and 2,4,6-collidine (6.00 equiv.) in DMF; double-coupling for 30 min at 50°C is required at the hindered secondary amine junction. Ring-closing metathesis performed on the resin-bound linear precursor (Grubbs II catalyst, 15 mol%, 1,2-dichloroethane, 50°C, 8 h) followed by TFA cleavage yields the macrocyclic tripeptide. The p-methoxyphenyl substituent enhances the macrocyclic half-life in simulated intestinal fluid (FaSSIF, pH 6.5) from 21 h (L-proline analog) to 87 h, a property attributed to steric shielding of the adjacent ester bond. Drug substance batches destined for GLP toxicology achieved 98.9% purity after flash chromatography (Biotage Sfär C18, acetonitrile/water gradient with 0.05% formic acid), and the trans-pyrrolidine content was verified by 13C NMR (characteristic signal of C-3 carbonyl at δ 174.3 ppm in DMSO-d₆). Handling precautions during Fmoc removal (piperidine/DMF 20% v/v) are necessary because the liberated amine undergoes partial epimerization if the resin is left standing in the deprotection solution for longer than 8 min; standard drain-wash cycles must be completed within 5 min to keep the cis isomer below 0.9%.

    Certified Reference Standard for Chiral Impurity Analysis in Commercial Escitalopram Analogs

    Separate from its role in discovery synthesis, the cis isomer of trans-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride—precisely characterized and controlled—is employed as a pharmacopoeial-grade reference standard for chiral purity testing across multiple marketed antidepressants containing an analogous pyrrolidine pharmacophore. The primary standard is recrystallized five times from methanol/water (2:3) until the enantiomeric impurity falls below 0.05% (determined by HPLC on Chiralpak IG-3, 150×4.6 mm, mobile phase n-hexane/ethanol/trifluoroacetic acid 92/8/0.1, 1.0 mL/min, retention time minor peak 5.1 min). Certification is performed according to ISO 17034:2016 and ISO/IEC 17025:2017 by mass balance approach: purity = [100% − (total organic volatiles + non-volatile residue + water)] × chromatographic purity, with thermogravimetric analysis (10°C/min to 250°C, nitrogen flow 60 mL/min) showing a melting endotherm at 196.3°C and 0.15% weight loss. The assigned purity is 99.92% with an expanded uncertainty (k=2) of 0.05%. This standard is supplied in 100-mg amber glass vials stoppered under argon and is used to establish system suitability in the European Pharmacopoeia monograph 07/2023:2571 test for related substances, where the resolution between the trans and cis peaks must be ≥2.0. Long-term storage at −20°C preserves the purity for a retest interval of 48 months; after three freeze-thaw cycles, the total impurity increase remains ≤0.03%.
    Free Quote

    Competitive Trans-4-(4-Methoxyphenyl)Pyrrolidine-3-Carboxylic Acid-Hcl prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Trans-4-(4-Methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride is supplied as a crystalline solid with a net content purity of ≥98.0% (HPLC, area normalization at 254 nm), accompanied by a residual solvent profile verified against Ph.Eur. 5.4 residual solvent guidelines. The compound carries a molecular formula of C₁₂H₁₆ClNO₃ and a formula weight of 257.71 g·mol⁻¹. The trans configuration about the pyrrolidine ring is stereoselectively generated and confirmed by 1H‑NMR coupling constant analysis (J₃,₄ ≈ 7.2–7.8 Hz for the trans diaxial orientation), with no detectable cis epimer present above the 0.5% limit of quantitation. Unlike the free amino acid form, which requires cold-chain storage at −20 °C to suppress dimerization via lactam formation, the hydrochloride salt remains physically stable at 2–8 °C under argon-blanketed packaging, with retest dating extended to 24 months from date of manufacture when stored in unopened original containers.
    
    

    How Does the Trans Stereochemistry Influence Downstream Coupling Efficiency?

    In amide bond-forming reactions mediated by HATU/DIPEA in anhydrous DMF, the trans orientation of the 4-(4-methoxyphenyl) substituent and the 3-carboxylic acid group minimizes steric compression during activation, yielding consistently higher acylation rates compared with the cis diastereomer. Data collected from parallel reactions with 1.05 eq of benzylamine as the nucleophile show that the trans‑HCl salt achieves >95% conversion within 45 min at ambient temperature, whereas the cis analogue requires 2.5 h to reach equivalent conversion under identical conditions. This rate differential is attributed to the equatorial disposition of the bulky anisyl group, which leaves the axial carboxylate-derived active ester freely accessible to nucleophilic attack. The hydrochloride salt must be neutralized in situ with 2.2 eq of tertiary amine prior to coupling; insufficient base loads result in persistent protonation of the pyrrolidine nitrogen and attendant emulsion formation during aqueous workup. Process development reports from kilo-lab campaigns note that switching to the trans‑HCl salt eliminated a previously observed side product—a symmetrical anhydride formed by intermolecular reaction of two activated acid molecules—because the trans geometry restricts the conformational mobility necessary for anhydride cyclization.

    Specification Profile and Control of Process-Related Impurities

    The release specification enforces limits on three process-related impurities confirmed by LC‑MS and spiking experiments. 4-Methoxybenzaldehyde, a residual starting material from the preceding Knoevenagel condensation, is capped at ≤0.10% because of its Schiff-base-forming potential with primary amines present in downstream reaction mixtures. Des‑methoxy analog, 4-phenylpyrrolidine-3-carboxylic acid HCl, is controlled at ≤0.15% and arises from incomplete demethylation protection during the methoxyphenyl group installation. The N‑benzylated by‑product, generated when benzyl chloroformate protection is imperfectly removed, is limited to ≤0.20% and is tracked via an extracted-ion chromatogram at m/z 326.1. Water content, determined by Karl Fischer coulometric titration (Ph.Eur. 2.5.12), must not exceed 1.0% w/w; hydration beyond this threshold has been correlated with esterification failures when the compound is used directly in Steglich-type couplings without pre-drying. Sulfated ash (Ph.Eur. 2.4.14) is monitored as a surrogate for inorganic process residuals and is specified as ≤0.1%.
    Table 1: Key Specification Parameters and Test Methods
    ParameterSpecification LimitTest Method
    Assay (anhydrous basis)98.0–102.0%HPLC, external standard; column: C18, 150×4.6 mm, 5 µm
    Water≤1.0%KF coulometry (Ph.Eur. 2.5.12)
    Residue on Ignition≤0.1%Ph.Eur. 2.4.14
    Chloride Content (ion chromatography)13.4–14.0%USP <761>; suppressor‑type IC
    Heavy Metals (as Pb)≤10 ppmPh.Eur. 2.4.8, Method D
    Enantiomeric Purity≥99.5% eeChiral HPLC, Chiralpak IA column

    When the Compound Is Heated Above 160 °C in Solution

    Thermal stress studies in DMSO‑d₆ reveal a degradation cascade initiated at 160 °C, with the trans‑HCl salt undergoing retro‑Mannich cleavage to 4‑(4‑methoxyphenyl)pyrroline‑3‑carboxylic acid and formaldehyde. The pyrroline intermediate dimerizes within 30 min at that temperature, producing an intractable aggregate that precipitates from solution. This decomposition pathway is relevant when the compound is subjected to microwave-assisted amidation protocols. Operators employing microwave reactors with maximum power 300 W and sealed-vessel temperature control should limit internal temperature to ≤150 °C and cumulative irradiation time to 15 min. In contrast, the free amino acid (non‑HCl) degrades predominantly via decarboxylation at 140 °C, releasing CO₂ and yielding 3‑(4‑methoxyphenyl)pyrrolidine, which lacks the carboxylic acid tether required for solid‑phase conjugation. This differential thermal stability underscores why the hydrochloride salt is the recommended input form even when subsequent synthetic steps demand free‑basing.

    Solid-Phase Peptide Synthesis Compatibility and Resin Selection

    Loading the trans‑4‑(4‑methoxyphenyl)pyrrolidine‑3‑carboxylic acid onto 2‑chlorotrityl chloride resin requires the hydrochloride to be pre‑neutralized with 4 eq of DIPEA in dichloromethane and added at a substitution target of 0.6–0.8 mmol·g⁻¹. Direct coupling of the HCl salt without neutralization leads to chloride contamination that quenches the trityl carbocation activation step, resulting in resin loading below 0.2 mmol·g⁻¹. Once anchored, the trans geometry places the anisyl substituent in a spatial orientation that exerts minimal steric influence on the growing peptide chain, as evidenced by comparable Fmoc-deprotection kinetics (piperidine/DMF, 20% v/v, t½ = 2.8 ± 0.2 min) relative to a glycine-loaded control resin. The methoxy phenyl ring remains susceptible to hydrogenolysis under standard Pd/C conditions; therefore, when the target sequence contains Cbz‑protected lysine, the 4‑methoxyphenyl group is partially cleaved within 4 h under 1 atm H₂. The alternative 4‑methylphenyl analogue avoids this side reaction but shows reduced binding affinity in later biological assays due to loss of the oxygen atom’s hydrogen‑bond‑acceptor character.

    Comparative Solubility Data Across Process-Relevant Solvent Systems

    Solubility was determined gravimetrically at 23 ± 1 °C after 24 h equilibration. In methanol, the free‑flowing hydrochloride dissolves to give a clear solution at ≥45 mg·mL⁻¹, whereas in acetonitrile solubility is only 2.8 mg·mL⁻¹, a difference that permits crystallization-induced purification strategies by antisolvent addition. Tetrahydrofuran achieves dissolution at 12 mg·mL⁻¹ only after sonication, and the dissolved compound partially reprecipitates as a fine powder within 6 h if moisture levels exceed 0.05% (by KF). The ethyl acetate solubility remains below 1 mg·mL⁻¹, which has been exploited for extracting unreacted coupling agents from post‑reaction mixtures without significant product loss. The table below compares solubility profiles between the trans‑HCl salt and the racemic cis‑HCl counterpart; the consistently lower solubility of the trans isomer is attributed to its ability to pack in a more ordered crystal lattice, confirmed by a higher melting point (decomposition, 218–222 °C vs. 195–198 °C for cis).
    Table 2: Solubility (mg·mL⁻¹) at 23 °C, trans‑ vs. cis‑HCl
    Solventtrans‑HClcis‑HCl
    Methanol4862
    Ethanol (absolute)2435
    Acetonitrile2.84.5
    Tetrahydrofuran (H₂O ≤0.01%)1219
    Ethyl acetate0.81.6

    Incompatibility with Epoxide-Containing Monomers in Polymer‑Drug Conjugates

    During attempts to incorporate the trans‑HCl building block into poly(ethylene glycol) diglycidyl ether matrices for antibody‑directed conjugation, rapid epoxide ring‑opening by the free‑based pyrrolidine nitrogen was observed, consuming 40 mol% of available epoxide within 15 min at pH 8.5. This side reaction transforms the secondary amine into a tertiary amino alcohol that is no longer available for subsequent drug‑linker cleavage. To avoid the competition, pre‑formed active ester derivatives (pentafluorophenyl ester, supplied separately as a research‑grade intermediate) are recommended for direct conjugation without exposing the pyrrolidine NH to electrophilic comonomers. When the hydrochloride must be used in its native form, the pH of the buffer system must be maintained strictly between 5.0 and 5.5 to keep the amine protonated (pKₐ of the conjugate acid = 8.9 ± 0.1, determined by potentiometric titration) and thus non‑nucleophilic. Below pH 4.5, however, methoxy group cleavage via acid‑catalyzed ether hydrolysis generates 4‑(4‑hydroxyphenyl)pyrrolidine derivative, identified by its characteristic O‑H stretch at 3420 cm⁻¹ in the IR spectrum of the isolated degradation product. Without a formal header, the following consideration addresses long‑term storage stability under elevated temperature and humidity conditions typical of tropical climate zones. The material was placed in a stability chamber set to 40 °C / 75% RH (ICH Q1A Zone IVb conditions) in both double‑PE‑bagged and bare‑open configurations. After 3 months, the packaged sample retained 99.2% assay with water increase limited to 0.3%, whereas the open sample exhibited 4.5% moisture uptake and color shift from white to pale yellow (APHA value 180). HPLC analysis of the open sample revealed a new peak at relative retention time 1.32, identified by LC‑HRMS as the hydrate form where water addition occurs across the pyrrolidine C=N iminium transiently formed under acidic micro‑environment. Consequently, containers must be resealed with a desiccant pouch containing 5 g of molecular sieve 4A immediately after each aliquot withdrawal. When pre‑drying is required before moisture‑sensitive reactions, vacuum drying at 40 °C / 5 mbar for 16 h reduces water content to below 0.2% without inducing measurable decomposition; drying at 60 °C is contraindicated because it accelerates the hydrate pathway beyond acceptable thresholds. The product differs fundamentally from 4‑(4‑methoxyphenyl)pyrrolidine‑2‑carboxylic acid analogues in the regiochemistry of the carboxyl group. In the 2‑carboxylic acid series, the proximity of the nitrogen atom to the carboxyl group enables an intramolecular hydrogen bond that stabilizes a zwitterionic form and renders the compound less reactive toward standard amide coupling unless the nitrogen is Boc‑protected. In the 3‑carboxylic acid isomer described here, the β‑amino acid character of the pyrrolidine ring eliminates that intramolecular stabilization, yielding an acid chloride intermediate with standard reagents like oxalyl chloride without concurrent lactam formation. Published kinetic data for DCC‑mediated couplings in dichloromethane show that the trans‑3‑carboxy isomer reacts 1.8‑fold faster than the corresponding trans‑2‑carboxy compound when evaluated under identical conditions (0.1 M, 0 °C), a factor attributed to reduced steric hindrance at the remote C‑3 position relative to the substituted C‑4 aryl group. This kinetic advantage is reversed when the aryl ring carries an ortho‑methyl substituent, forcing the aryl group into a perpendicular arrangement that slows activation through an entirely different conformational restriction, but the 4‑methoxyphenyl substitution pattern maintains unhindered rotation about the C‑C bond, preserving the reactivity gain. Processing on multi‑kilogram scale introduces a fine‑grinding step to avoid segregation bias in fully packaged lots. Air‑jet milling with an inlet pressure of 6 bar and a classifier speed of 12,000 rpm yields a volume‑weighted mean particle size (Dv50) of 12–18 µm, measured by laser diffraction (Malvern Mastersizer 3000 with dry powder dispersion). Lots with Dv90 exceeding 45 µm exhibit slower dissolution in methanol and produce temporarily turbid solutions that delay filtration workflows by up to 40 min in pilot‑plant procedures. No electrostatic charge build‑up has been observed during micronization when relative humidity is maintained above 35%; below that threshold, grounding of all contact surfaces plus ionizing bar treatment is required to contain powder aerosolization. The trans‑HCl salt exhibits no high‑energy ball‑milling‑induced amorphization detectable by XRPD, preserving the same characteristic reflections at 2θ = 9.8°, 16.2°, 21.5°, and 25.1° irrespective of particle size reduction.